Lupin

Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and Active Pharmaceutical Ingredients (APIs). Founded over 50 years ago, Lupin today is a significant player in the US, India and Japan and additionally in other counties within APAC, EMEA and LATAM. It holds a global leadership position in Anti-TB and Cephalosporin segments. Today Lupin is focused on building a meaningful pipeline in women’s health in USA, Neurology in Europe and Japan, Cardiac, Diabetes and Respiratory in India and Ophthalmic and Dermatology in LATAM. With 18 world class manufacturing facilities benchmarked to international standards, are spread across India, Japan, USA, Mexico and Brazil. Our 20,000 strong team of experts embrace the values of Lupin to create a winning culture as well as engage in leading research programs from new drug discovery to generic research that is helping us meet the unmet medical needs of our customers around the world.

Website

http://www.lupin.com

Externer Link zu Lupin

Branche

Arzneimittelherstellung

Größe

10.001 Beschäftigte

Hauptsitz

Mumbai, Maharashtra

Art

Kapitalgesellschaft (AG, GmbH, UG etc.)

Spezialgebiete

Specialty Pharmaceuticals, Complex Generics, Biotechnology, APIs, Drug Delivery Systems, Biosimilars, Biologics und Global Formulations